NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

PFE

Pfizer Inc

Apr 25 • 04:00PM ET

22.92

Dollar change +0.14
Percentage change 0.61	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN

| Held by: VTI VOO SPY IVV VTV XLV VYM VHT COWZ DVY

Scroll to Statements

Index	S&P 500	P/E	16.28	EPS (ttm)	1.41	Insider Own	0.04%	Shs Outstand	5.67B	Perf Week	3.52%
Market Cap	129.99B	Forward P/E	7.58	EPS next Y	3.02	Insider Trans	0.80%	Shs Float	5.67B	Perf Month	-9.08%
Income	8.02B	PEG	-	EPS next Q	0.67	Inst Own	67.32%	Short Float	1.90%	Perf Quarter	-12.15%
Sales	63.63B	P/S	2.04	EPS this Y	-5.12%	Inst Trans	-0.65%	Short Ratio	2.10	Perf Half Y	-20.53%
Book/sh	15.56	P/B	1.47	EPS next Y	2.50%	ROA	3.65%	Short Interest	107.43M	Perf Year	-12.92%
Cash/sh	3.61	P/C	6.35	EPS next 5Y	-1.57%	ROE	9.05%	52W Range	20.92 - 31.54	Perf YTD	-13.61%
Dividend Est.	1.71 (7.44%)	P/FCF	13.22	EPS past 5Y	-13.25%	ROI	5.42%	52W High	-27.33%	Beta	0.56
Dividend TTM	1.69 (7.37%)	Quick Ratio	0.92	Sales past 5Y	17.19%	Gross Margin	66.76%	52W Low	9.59%	ATR (14)	0.71
Dividend Ex-Date	May 09, 2025	Current Ratio	1.17	EPS Y/Y TTM	272.80%	Oper. Margin	26.92%	RSI (14)	44.39	Volatility	2.50% 3.46%
Employees	81000	Debt/Eq	0.76	Sales Y/Y TTM	8.77%	Profit Margin	12.60%	Recom	2.46	Target Price	28.11
Option/Short	Yes / Yes	LT Debt/Eq	0.68	EPS Q/Q	112.15%	Payout	119.94%	Rel Volume	0.70	Prev Close	22.78
Sales Surprise	2.38%	EPS Surprise	33.59%	Sales Q/Q	24.66%	Earnings	Apr 29 BMO	Avg Volume	51.09M	Price	22.92
SMA20	-0.11%	SMA50	-7.55%	SMA200	-15.33%	Trades		Volume	35,793,488	Change	0.61%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60

Show Previous Ratings

Today 02:32PM	1 Superstar Dividend Growth Stock to Buy if the Market Crashes (Motley Fool)
01:30PM	Pfizers Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer (Business Wire)
01:30PM	Pfizer's Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naive, High-Risk Non-Muscle Invasive Bladder Cancer (Business Wire)
11:00AM	Microsoft, Apple Set To Report Earnings As Markets Watch Out For Core PCE Price Index (Seeking Alpha)
09:30AM	Summit Therapeutics: New Ivonescimab Data Raise Concerns (Seeking Alpha)
05:30PM	Loading…
Apr-25-25 05:30PM	Investing Action Plan: Apple, Amazon, Pfizer, Caterpillar And Sparring With The Fed (Investor's Business Daily)
11:00AM	Biohaven stock slides on withdrawal of European marketing application (BioPharma Dive)
07:06AM	Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season? (Zacks)
Apr-24-25 03:36PM	Guardant Health, Pfizer Collaborate To Develop New Cancer Therapies Using Liquid Biopsy Platform (Benzinga)
01:52PM	Is Pfizer Stock A Sell After Abandoning Yet Another Obesity Drug? (Investor's Business Daily)
11:54AM	BMY Beats on Q1 Earnings and Sales, Raises 2025 Outlook (Zacks)
11:40AM	PFE vs. LLY: Which Stock Should Value Investors Buy Now? (Zacks)
10:01AM	Eli Lilly (LLY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
09:40AM	Are Investors Undervaluing Pfizer (PFE) Right Now? (Zacks)
09:15AM	Curious about Pfizer (PFE) Q1 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
08:49AM	Loading…
08:49AM	Stocks That Pay Almost 10% Dividend Yields: Dow and Lyondell (Barrons.com)
08:30AM	5 All-Weather Dividend Stocks to Buy Right Now (Motley Fool)
08:05AM	Guardant Health Announces Strategic Collaboration With Pfizer to Support Development and Commercialization of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy Platform (Business Wire)
07:59AM	Sanofi Q1 Earnings Top Estimates, Dupixent Drives Sales Growth (Zacks)
06:45AM	2 No-Brainer Stocks to Buy With Less Than $30 (Motley Fool)
05:16AM	Pfizer CEO Albert Bourla sees a scientific renaissance in the U.S. amid backdrop of political threats to the future of research (Fortune)
04:51AM	Should You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500? (Motley Fool)
Apr-23-25 05:45PM	Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know (Zacks)
04:40PM	Pfizer Declares Second-Quarter 2025 Dividend (Business Wire)
03:47PM	Why Is Summit Therapeutics Stock Soaring On Wednesday? (Benzinga)
03:46PM	Pfizer Advances Bold Vision for Future of Cancer Care at the ASCO 2025 Annual Meeting (Business Wire)
02:50PM	Why vaccine makers aren't worried about Trump administration cuts (Yahoo Finance)
01:52PM	Pfizer Earnings Preview: Pharma May Plumb New Depths After Obesity Drug Debacle (Seeking Alpha)
08:30AM	2 High-Yield Dividend Stocks to Buy for Passive Income (Motley Fool)
06:58AM	Pfizer Stock Before Q1 Earnings Release: To Buy or Not to Buy? (Zacks)
06:40AM	Loading…
06:40AM	What's Next for Pfizer After the Company Pulls Its Weight Loss Drug? (Motley Fool)
05:07AM	Is Eli Lilly Stock a Buy? (Motley Fool)
03:51AM	S&P 500 Sell-Off: 2 Ultra-High-Yield Dividend Stocks That Make for No-Brainer Buys (Motley Fool)
03:40AM	Magnificent 7 Earnings Out This Week Will Shed Light On Big Tech's Tariff Concerns (Seeking Alpha)
Apr-22-25 04:06PM	Novo Nordisk Pops After Leapfrogging Eli Lilly With An Obesity Pill (Investor's Business Daily)
01:44PM	Jim Cramer Warns on Pfizer (PFE): "That 7.7% Yield Is Not a Sign of Strength - It's a Sign of Weakness" (Insider Monkey)
10:00AM	Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for (Zacks)
09:36AM	Pfizer Inc. (PFE): Among Recent Activist Investor Campaigns (Insider Monkey)
09:00AM	Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know (Zacks)
07:40AM	Celldex Therapeutics: Strong Pipeline But Uncertainties Remain (Seeking Alpha)
04:34AM	Novo shares down on Eli Lillys positive obesity pill data (Investing.com)
Apr-21-25 02:00PM	How To Build A $500,000 Dividend Portfolio That Could Yield 18.35% In 20 Years (Seeking Alpha)
10:19AM	Pfizer Inc. (PFE): One of the Safe Dividend Stocks with Yields Above 5% (Insider Monkey)
04:00AM	How a scrapped Pfizer drug became a winner for SpringWorks (Pharma Voice)
03:55AM	Pfizer: Is The Dividend Yield Worth The Effort (Seeking Alpha)
Apr-20-25 10:00PM	How To Put $100 In Your Retirement Fund Each Month With Pfizer Stock (Benzinga)
10:15AM	Bullish On Akeso's Ivonescimab, But Valuation And Geopolitical Risks Remain (Seeking Alpha)
09:00AM	Eli Lilly: A New Leader In Weight Loss Drugs Is Clearly Emerging (Seeking Alpha)
05:45AM	3 Ultra-High-Yield Dividend Stocks to Buy Right Now That Are Dirt Cheap (Motley Fool)
Apr-19-25 11:57AM	Pfizer Inc. (PFE): Among Jeff Smith's Top Activist Targets (Insider Monkey)
08:30AM	3 Magnificent Stocks to Buy That Are Near 52-Week Lows (Motley Fool)
Apr-18-25 08:15AM	Pfizer Abandons Its Leading Weight Loss Candidate. Should You Sell the Stock? (Motley Fool)
03:05AM	3 Magnificent S&P 500 Dividend Stocks Down 11% to 63% to Buy and Hold Forever (Motley Fool)
Apr-17-25 08:56PM	Lilly Soars As Study Shows Weight-Loss Pill to Pass Ozempic (Bloomberg)
05:45PM	Pfizer (PFE) Laps the Stock Market: Here's Why (Zacks)
05:07PM	Nurix Therapeutics: IRAK4 GS-6971 Isn't Only Protein Degrader With Big Potential (Seeking Alpha)
03:31PM	US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years (Benzinga)
02:50PM	Is Pfizer Inc. (PFE) the Best Large-Cap Value Stock to Buy as the Recession Hits? (Insider Monkey)
01:45PM	Eli Lilly: Cementing Its GLP-1 Empire With Orforglipron's Promising Phase 3 Results (Seeking Alpha)
01:06PM	Should You Buy, Hold, or Sell BMY Stock Ahead of Q1 Earnings? (Zacks)
12:46PM	Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide (Motley Fool)
10:51AM	Vaccine Stocks Rise on Growing Threat of Bird Flu Infections (Zacks)
09:20AM	GSK & PFE's RSV Vaccines Recommended for Use in Adults Aged 50-59 (Zacks)
09:15AM	Pharma Stock Roundup: J&J's Q1 Results, PFE's Obesity Setback (Zacks)
09:00AM	Eli Lilly Stock Soars on Oral Weight-Loss Drug Trial Results (Investopedia)
08:10AM	My Dividend Stock Portfolio: New All-Time Dividend Record In March - 100 Holdings With 15 Buys (Seeking Alpha)
05:00AM	CDC panel backs broader use of RSV shots (BioPharma Dive)
03:51AM	Trump Tariff Plunge: 3 Phenomenal Stocks to Buy at Bargain Prices Right Now (Motley Fool)
12:58AM	Pfizer: Risks Priced In, Buy The Exceptional Valuation And Yield (Seeking Alpha)
Apr-16-25 04:29PM	Analyst Report: Pfizer Inc. (Morningstar Research)
04:15PM	ACIP Votes to Expand Recommendation for Pfizer's RSV Vaccine ABRYSVO to Include Adults Aged 50 to 59 at Increased Risk of Disease (Business Wire)
03:28PM	Pfizer: Tasty 7% Yield (Seeking Alpha)
09:45AM	Top Cancer Stocks to Buy to Boost Your Portfolio's Health (Zacks)
04:52AM	Valneva SE: Initiating Hold Rating Based On Potentially Limited Upside (Seeking Alpha)
Apr-15-25 09:50PM	Parnassus Value Select ETF Q1 2025 Commentary (Seeking Alpha)
06:53PM	Why Pfizer Stock Topped the Market on Tuesday (Motley Fool)
04:21PM	Viking Therapeutics: Trading The Volatility Of The Weight Loss Drug Market (Seeking Alpha)
02:37PM	Viking Therapeutics' VK2735 Candidate Likely Boosted By Pfizer's Woes (Seeking Alpha)
12:57PM	Pfizer Halts Obesity Pill Development Amid Safety Concerns (Zacks)
12:54PM	Squawk Pod: VA Governor Youngkin on DOGE & $2.2B to Harvard on hold - 04/15/25 Audio Only (CNBC TV)
11:05AM	BofA keeps Neutral on Pfizer after danuglipron failure as core thesis unchanged (TipRanks)
10:43AM	Johnson & Johnson: First Look At Q1 Earnings - Solid Quarter Will Calm Nerves (Seeking Alpha)
10:35AM	Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill (TipRanks)
10:00AM	NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback (Zacks)
09:09AM	The Tariff Game Just Changed: 7 Blue-Chip Bargains To Buy Now (Seeking Alpha)
07:39AM	Is High-Yield Pfizer Stock Still a Buy After Scrapping Its Weight-Loss Pill? (Motley Fool)
Apr-14-25 11:32PM	Trump Initiates Chips and Drug Probes Ahead of More Tariffs (Bloomberg)
05:44PM	Pfizer hits setback in obesity drug race as GLP-1 trial halts (Yahoo Finance Video)
05:15PM	Top Analyst Reports for Bank of America, Chevron & Stryker (Zacks)
03:55PM	Stocks to Watch Monday: Apple, Palantir, Intel, Pfizer (The Wall Street Journal)
01:29PM	Dell stock pops, Pfizer halts GLP-1 pill trial, M&T Bank outlook (Yahoo Finance Video)
12:53PM	Pfizer Inc. (PFE): "Dead Money… Close the Casket," Says Jim Cramer (Insider Monkey)
12:45PM	Pfizer drops obesity pill development after liver injury report (Clinical Trials Arena)
11:18AM	Pfizer's $130B Weight-Loss Dream Just Collapsed (GuruFocus.com)
11:15AM	Pfizer Halts Obesity-Drug Development. What It Means for Eli Lilly, Novo Nordisk. (Barrons.com)
11:12AM	Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today (Motley Fool)
10:55AM	Pfizer just had a big setback in its race for an Ozempic competitor (Quartz)
10:50AM	Wall Street Lunch: Apple Leads Q1 Global Smartphone Sales (Seeking Alpha)
10:37AM	Pfizer, Nvidia, Intel: Stocks in 30 (Yahoo Finance Video)
10:36AM	Pfizer Halts Development of Weight-Loss Pill (The Wall Street Journal)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM
McDermott Michael	Executive Vice President	Feb 22 '25	Option Exercise	30.17	11,125	335,641	87,636	Feb 25 07:38 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22 '25	Option Exercise	30.17	8,741	263,716	17,602	Feb 25 07:38 PM
BOURLA ALBERT	Chairman & CEO	Feb 22 '25	Option Exercise	30.17	238,399	7,192,498	570,436	Feb 25 07:06 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 22 '25	Option Exercise	30.17	85,824	2,589,310	232,775	Feb 25 07:05 PM
SAHNI PAYAL	Executive Vice President	Feb 22 '25	Option Exercise	30.17	12,714	383,581	37,099	Feb 25 07:04 PM
SUSMAN SALLY	Executive Vice President	Feb 22 '25	Option Exercise	30.17	63,573	1,917,997	225,184	Feb 25 07:02 PM
BOSHOFF CHRISTOFFEL	President, R&D	Feb 22 '25	Option Exercise	30.17	8,741	263,716	159,085	Feb 25 06:58 PM
BLAYLOCK RONALD E	Director	Feb 13 '25	Buy	25.65	19,457	499,072	27,707	Feb 14 05:16 PM
Gottlieb Scott	Director	Oct 30 '24	Buy	28.24	1,000	28,240	10,000	Oct 31 04:06 PM
DAMICO JENNIFER B.	SVP & Controller	Aug 13 '24	Sale	28.66	5,154	147,714	8,582	Aug 14 03:47 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc

Upgrade your FINVIZ experience